tiprankstipranks
Advertisement
Advertisement
The Week That Was, The Week Ahead: Macro and Markets, Mar. 29
PremiumMarket NewsThe Week That Was, The Week Ahead: Macro and Markets, Mar. 29
4d ago
Bristol-Myers Squibb’s Repotrectinib DDI Study: What Investors Should Watch
Premium
Company Announcements
Bristol-Myers Squibb’s Repotrectinib DDI Study: What Investors Should Watch
6d ago
Milvexian Phase 3 Wraps Up: What Bristol-Myers Squibb Investors Should Watch Next
Premium
Company Announcements
Milvexian Phase 3 Wraps Up: What Bristol-Myers Squibb Investors Should Watch Next
6d ago
Bristol Myers announces presentation of new trial, data for Camzyos
PremiumThe FlyBristol Myers announces presentation of new trial, data for Camzyos
10d ago
Bristol Myers announces expanded approvals for Opdivo in U.S., EU,
Premium
The Fly
Bristol Myers announces expanded approvals for Opdivo in U.S., EU,
12d ago
Trump Trade: President issues short-term waiver of Jones Act
Premium
The Fly
Trump Trade: President issues short-term waiver of Jones Act
15d ago
BMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis
PremiumCompany AnnouncementsBMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis
20d ago
Colgate-Palmolive names Bristol-Myers CEO Boerner to board
Premium
The Fly
Colgate-Palmolive names Bristol-Myers CEO Boerner to board
20d ago
Curanex appoints two research experts to board of directors
Premium
The Fly
Curanex appoints two research experts to board of directors
22d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100